Search Results 271-280 of 18170 for peptide therapy
Ubrogepant (Ubrelvy) and rimegepant (Nurtec ODT) are oral calcitonin gene-related peptide (CGRP) receptor antagonists approved for the treatment of acute ...
The serum brain natriuretic peptide was markedly ... Aggressive therapy was started with 200 mg of ... Thyroidectomy should be pursued when medical therapy fails to ...
... peptide receptor radionuclide therapy (PRRT) to the usual approach of treatment with everolimus in patients who have previously received 177Lu-DOTATATE for ...
The purpose of this study is to investigate ghrelin, a peptide that mechanistically carries the promise of therapeutics benefit for diverse aspects of morbidity ...
MemberOrganizing Committee, Second Mayo Symposium on the Natriuretic Peptides, Division of Cardiovascular Diseases. Show more professional memberships ...
... Peptide Receptor Radionuclide Therapy for Patients With Neuroendocrine Tumors. Front Oncol. 2018; 8:663 Epub 2019 Jan 09. View PubMed; Bowman AW, Albers BK ...
The purpose of this study is to investigate the facilitators and barriers of adults with a history of cocaine use disorder (CocUD) in sustained remission to ...
... therapy, Mayo Clinic will work with you to schedule treatment. The appointment time depends on several factors, including your condition, laboratory ...
When to see a doctor. The condition usually clears up without treatment. See your health care provider if: The discolored, mottled skin doesn't go away with ...
... peptide (CGRP) which may be relevant for future therapeutic considerations within this patient population. A Study of Disease Prediction for NOTCH3 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!